Search

Your search keyword '"Membrane Transport Proteins antagonists & inhibitors"' showing total 274 results

Search Constraints

Start Over You searched for: Descriptor "Membrane Transport Proteins antagonists & inhibitors" Remove constraint Descriptor: "Membrane Transport Proteins antagonists & inhibitors"
274 results on '"Membrane Transport Proteins antagonists & inhibitors"'

Search Results

1. Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations.

2. Novel parent structures for inhibitors of the murine GABA transporters mGAT3 and mGAT4.

3. Uridine binding and transportability determinants of human concentrative nucleoside transporters.

4. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.

5. Subtype-specific GABA transporter antagonists synergistically modulate phasic and tonic GABAA conductances in rat neocortex.

6. GABAergic modulation of the activity of globus pallidus neurons in primates: in vivo analysis of the functions of GABA receptors and GABA transporters.

7. Inhibitors of efflux pumps in Gram-negative bacteria.

8. Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos.

9. Mechanism and regulation of human intestinal niacin uptake.

10. The era of ESSTIs is slowly approaching?

11. Vinylogous amide analogs of methylphenidate.

12. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.

13. Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds.

14. Lobelane analogues as novel ligands for the vesicular monoamine transporter-2.

15. Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation.

16. A role for phosphorylation in the regulation of the barley scutellar peptide transporter HvPTR1 by amino acids.

17. Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis.

18. Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin.

19. Interhelical packing modulates conformational flexibility in the lactose permease of Escherichia coli.

20. Quantitative analysis of immunolabeling for serotonin and for glutamate transporters after administration of imipramine and citalopram.

21. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.

22. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

23. Time-dependent changes in receptor/G-protein coupling in rat brain following chronic monoamine transporter blockade.

24. Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials.

25. 5-Hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells are extracellular signal-regulated kinase pathway dependent.

26. Zinc inhibition of gamma-aminobutyric acid transporter 4 (GAT4) reveals a link between excitatory and inhibitory neurotransmission.

27. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.

28. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.

29. Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement product.

30. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.

31. Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier.

32. Physiological, pharmacological and clinical features of the multidrug resistance protein 2.

33. The role of N-glycosylation in the stability, trafficking and GABA-uptake of GABA-transporter 1. Terminal N-glycans facilitate efficient GABA-uptake activity of the GABA transporter.

34. The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects.

35. Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.

36. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.

37. Decreased platelet vesicular monoamine transporter density in habitual smokers.

38. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.

39. Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130.

40. Synthesis and biological evaluation of new GABA-uptake inhibitors derived from proline and from pyrrolidine-2-acetic acid.

41. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.

42. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.

43. Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatum.

44. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.

45. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells.

46. GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal.

47. Psychostimulants and monoamine transporters: upsetting the balance.

48. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies.

49. Inhibitors of multidrug efflux transporters: their membrane and protein interactions.

50. Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality.

Catalog

Books, media, physical & digital resources